Krakow, Poland – 31 March 2020 – Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, today announced that Pawel Przewiezlikowski, Chief Executive Officer, will present a corporate overview at the upcoming Solebury Trout Virtual Investor Conference. The 25-minute presentation will include an interactive Q&A with participants prompted to submit questions electronically.

Details are as follows:

Date/time: Thursday, April 2, 2020 at 12:30 PM (ET)

Access via webcast link: https://78449.themediaframe.com/dataconf/productusers/solebury/mediaframe/36519/indexl.html